Aurinia Pharmaceuticals Inc is a clinical stage pharmaceutical company. Its focused on the development of its novel therapeutic immunomodulating drug candidate, voclosporin, for the treatment of lupus nephritis.
Website: | www.auriniapharma.com |
Main Phone: | +1 250 708-4272 |
Address: | 4464 Markham Street |
Address 2: | Suite 1203 |
State: | BC |
City / Town: | Victoria |
Country: | CAN |
Postal Code: | V8Z 7X8 |
Exchange: | TSX |
Employees: | 16 |
NAICS: | Pharmaceutical P |
Last Price 7.03 | Change $ 0.10 | Change % 1.44 | Tick N/A |
Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
Open 7.02 | High 7.03 | Low 6.94 | Prev Close 6.93 |
Last Trade | Volume 400 | 52 Wk Hi 11.02 | 52 Wk Low 5.70 |
Market Cap 590.9 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
Shares 84,051,758.00 | EPS (TTM) -1.20 | PE Ratio N/A | Exchange TSX |
Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
---|---|---|---|---|
High Target Price Estimate | 10.89 | 10.89 | 10.89 | 10.89 |
Low Target Price Estimate | 10.89 | 10.89 | 10.89 | 10.89 |
Mean Target Price Estimate | 10.89 | 10.89 | 10.89 | 10.89 |
Standard Deviation | 0 | 0 | 0 | 0 |
Date of Most Recent Estimate | 03/29/16 | 03/29/16 | 03/29/16 | 03/29/16 |
Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 1 |
Moderate Buy | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 |
Moderate Sell | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 |
Mean Rec. | 0 | 0 | 0 | 1 |